Private-equity owned sterilization company Sotera Health is considering a potential sale that could be worth as much as $5 billion, according to a recent Reuters report.
Company owners Warburg Pincus and GTCR are working with investment banks in pursuit of a sale of the company, though the process is still in its early stages and there is no guarantee that a deal will emerge, according to the report.
Warburg Pincus declined to comment, while GTCR and Sotera did not immediately respond to requests for comment, Reuters reports.
Sotera was picked up by GTCR in 2011 from Silverfleet Capital and PPM America Capital Partners, and sold a majority stake to Warburg Pincus in 2015, according to the report.
In April, Sotera Health said that it inked a deal to sell the medical isotopes segment of its Nordion business to a subsidiary of BWX Technologies for an undisclosed amount.
